These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
485 related articles for article (PubMed ID: 9921922)
21. Decreased activity of cathepsins L + B and decreased invasive ability of PC3 prostate cancer cells. Colella R; Casey SF Biotech Histochem; 2003 Apr; 78(2):101-8. PubMed ID: 14533846 [TBL] [Abstract][Full Text] [Related]
22. Imbalance between cysteine proteases and inhibitors in a baboon model of bronchopulmonary dysplasia. Altiok O; Yasumatsu R; Bingol-Karakoc G; Riese RJ; Stahlman MT; Dwyer W; Pierce RA; Bromme D; Weber E; Cataltepe S Am J Respir Crit Care Med; 2006 Feb; 173(3):318-26. PubMed ID: 16166622 [TBL] [Abstract][Full Text] [Related]
23. Cystatins and cathepsins in breast carcinoma. Lah TT; Kokalj-Kunovar M; Drobnic-Kosorok M; Babnik J; Golouh R; Vrhovec I; Turk V Biol Chem Hoppe Seyler; 1992 Jul; 373(7):595-604. PubMed ID: 1515089 [TBL] [Abstract][Full Text] [Related]
24. Cathepsins B and L and their inhibitors stefin B and cystatin C as markers for malignant progression of benign meningiomas. Trinkaus M; Vranic A; Dolenc VV; Lah TT Int J Biol Markers; 2005; 20(1):50-9. PubMed ID: 15832773 [TBL] [Abstract][Full Text] [Related]
25. Structural basis for different inhibitory specificities of human cystatins C and D. Hall A; Ekiel I; Mason RW; Kasprzykowski F; Grubb A; Abrahamson M Biochemistry; 1998 Mar; 37(12):4071-9. PubMed ID: 9521728 [TBL] [Abstract][Full Text] [Related]
26. Expression of cysteine protease inhibitors stefin A, stefin B, and cystatin C in human lung tumor tissue. Ebert E; Werle B; Jülke B; Kopitar-Jerala N; Kos J; Lah T; Abrahamson M; Spiess E; Ebert W Adv Exp Med Biol; 1997; 421():259-65. PubMed ID: 9330706 [TBL] [Abstract][Full Text] [Related]
27. Lysosomal peptidases and glycosidases in rheumatoid arthritis. Sohar N; Hammer H; Sohar I Biol Chem; 2002 May; 383(5):865-9. PubMed ID: 12108554 [TBL] [Abstract][Full Text] [Related]
28. Contributions of individual residues in the N-terminal region of cystatin B (stefin B) to inhibition of cysteine proteinases. Pol E; Björk I Biochim Biophys Acta; 2003 Jan; 1645(1):105-12. PubMed ID: 12535617 [TBL] [Abstract][Full Text] [Related]
29. Reduced cystatin B activity correlates with enhanced cathepsin activity in progressive myoclonus epilepsy. Rinne R; Saukko P; Järvinen M; Lehesjoki AE Ann Med; 2002; 34(5):380-5. PubMed ID: 12452481 [TBL] [Abstract][Full Text] [Related]
30. Regulation of the activity of lysosomal cysteine proteinases by pH-induced inactivation and/or endogenous protein inhibitors, cystatins. Turk B; Bieth JG; Björk I; Dolenc I; Turk D; Cimerman N; Kos J; Colic A; Stoka V; Turk V Biol Chem Hoppe Seyler; 1995 Apr; 376(4):225-30. PubMed ID: 7626231 [TBL] [Abstract][Full Text] [Related]
31. Toward understanding recurrent meningioma: the potential role of lysosomal cysteine proteases and their inhibitors. Lah TT; Nanni I; Trinkaus M; Metellus P; Dussert C; De Ridder L; Rajcević U; Blejec A; Martin PM J Neurosurg; 2010 May; 112(5):940-50. PubMed ID: 19747051 [TBL] [Abstract][Full Text] [Related]
32. Grafting of features of cystatins C or B into the N-terminal region or second binding loop of cystatin A (stefin A) substantially enhances inhibition of cysteine proteinases. Pavlova A; Björk I Biochemistry; 2003 Sep; 42(38):11326-33. PubMed ID: 14503883 [TBL] [Abstract][Full Text] [Related]
33. [Cysteine proteinases and their inhibitors in the development of mouse HA-1 hepatoma and antineoplastic therapy]. Poteriaeva ON; Korolenko TA; Svechnikova IG; Zhanaeva SIa; Falameeva OV; Kaledin VI; Nowicky JW Biomed Khim; 2004; 50(2):172-9. PubMed ID: 15179824 [TBL] [Abstract][Full Text] [Related]
34. Collagenolytic cathepsins of rabbit spleen: a kinetic analysis of collagen degradation and inhibition by chicken cystatin. Maciewicz RA; Etherington DJ; Kos J; Turk V Coll Relat Res; 1987 Sep; 7(4):295-304. PubMed ID: 3665403 [TBL] [Abstract][Full Text] [Related]
35. Alterations of cathepsins B, H and L in proximal tubules from polycystic kidneys of the Han:SPRD rat. Schaefer L; Han X; Gretz N; Schaefer RM Kidney Int; 1996 Aug; 50(2):424-31. PubMed ID: 8840269 [TBL] [Abstract][Full Text] [Related]
36. Baboon (Papio ursinus) cathepsin L: purification, characterization and comparison with human and sheep cathepsin L. Coetzer TH; Dennehy KM; Pike RN; Dennison C Comp Biochem Physiol B Biochem Mol Biol; 1995 Nov; 112(3):429-39. PubMed ID: 8529021 [TBL] [Abstract][Full Text] [Related]
37. Matrix metalloproteinases, but not cathepsins B, H, and L or their inhibitors in peripheral blood of patients with rheumatoid arthritis are potentially useful markers of disease activity. Keyszer G; Lambiri I; Keysser M; Keysser C; Nagel R; Burmester GR; Jung K Z Rheumatol; 1998 Dec; 57(6):392-8. PubMed ID: 10025098 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of bovine cathepsins L and S by stefins and cystatins. Leonardi A; Turk B; Turk V Biol Chem Hoppe Seyler; 1996 May; 377(5):319-21. PubMed ID: 8828823 [TBL] [Abstract][Full Text] [Related]
39. The contribution of N-terminal region residues of cystatin A (stefin A) to the affinity and kinetics of inhibition of papain, cathepsin B, and cathepsin L. Estrada S; Pavlova A; Björk I Biochemistry; 1999 Jun; 38(22):7339-45. PubMed ID: 10353845 [TBL] [Abstract][Full Text] [Related]
40. Role of the single cysteine residue, Cys 3, of human and bovine cystatin B (stefin B) in the inhibition of cysteine proteinases. Pol E; Björk I Protein Sci; 2001 Sep; 10(9):1729-38. PubMed ID: 11514663 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]